Evolutionary hypothesis of the Mevalonate Kinase Deficiency

Medical Hypotheses

Volumn 80, Issue 1, 2013, Pages 67-69

  Vuch, J ^a   Marcuzzi, A ^a   Bianco, A M ^a   Tommasini, A ^a   Zanin, V ^a   Crovella, S ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MEVALONATE KINASE;

ARTICLE; FAT INTAKE; GENE MUTATION; HETEROZYGOTE; HUMAN; MEVALONATE KINASE DEFICIENCY;

BIOLOGICAL EVOLUTION; CHOLESTEROL; DIET, HIGH-FAT; EUROPE; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEVALONATE KINASE DEFICIENCY; MODELS, BIOLOGICAL; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SELECTION, GENETIC;

ANIMALIA;

EID: 84870861478     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.10.016     Document Type: Article

References (11)

1. Simon A., Mariman E.C., van der Meer J.W., Drenth J.P. A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome. Am J Med 2003, 114:148-152.
2. Kuijk L.M., Beekman J.M., Koster J., Waterham H.R., Frenkel J., Coffer P.J. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood 2008, 112:3563-3573.
3. Mandey S.H., Schneiders M.S., Koster J., Waterham H.R. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat 2006, 27:796-802.
4. Haas D., Hoffmann G.F. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 2006, 1:13.
5. Simon A., Bijzet J., Voorbij H.A., Mantovani A., van der Meer J.W., Drenth J.P. Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J Intern Med 2004, 256:247-253.
6. Marcuzzi A., Decorti G., Pontillo A., Ventura A., Tommasini A. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010, 59:335-338.
7. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia. J Lipid Res 2005, 46:2037-2051.
8. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
9. Houten S.M., van Woerden C.S., Wijburg F.A., Wanders R.J., Waterham H.R. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 2003, 11:196-200.
10. Caspari R. The evolution of grandparents. Sci Am 2011, 305:44-49.
11. Zeegers M.P., van Poppel F., Vlietinck R., Spruijt L., Ostrer H. Founder mutations among the Dutch. Eur J Hum Genet 2004, 12:591-600.